Clifford Chance advises on Sanofi’s successful SEC-registered USD 3 billion bond issuance across five tranches of floating and fixed rate notes

Clifford Chance acted as counsel to Barclays Capital Inc., BNP Paribas Securities Corp. and BofA Securities, Inc. as Global Coordinators and Joint Book-Running Managers and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc. and Natixis Securities Americas LLC as Joint Book-Running Managers on Sanofi’s successful SEC-registered USD 3 billion bond issuance.

The bond issuance featured two tranches of floating rate notes and three tranches of fixed-rate notes, with maturities ranging from two to seven years.

Sanofi, listed on NASDAQ and Euronext, is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

The Clifford Chance team was led by Olivier Plessis, with key support from Jill Concannon, Trey Oxendine and Tara Kade in London and Cedric Burford, Auriane Bijon and Baya Hariche in Paris. Additional support was provided on US and French tax matters by Avrohom Gelber and Gil Shauly in New York and Pierre Goyat and Hanene Zemir in Paris.